Arvee Laboratories (India) Limited

NSE: ARVEESpecialty ChemicalsASM stage 1

Share price

₹212.08

+0.14% close of 8 Oct 2026

Market cap ₹234 CrP/E 57.7

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 8 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹234 Cr

P/E ratio

57.7

P/B ratio

6.9

ROCE

7.5%

ROE

7.8%

Dividend yield

0.0%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹290.7852-week low ₹133.86

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Our sales figures for this company step up at Sep 2019 and we hold nothing that says why, so we cannot honestly quote a growth rate across it.

Whether it grew faster than its sector

Our sales figures for this company step up at Sep 2019 and we hold nothing that says why, so there is no honest growth rate of its own to set against its sector.

Room to re-rate, or risk of de-rating

At 57.7× earnings it costs 2.4× the market, which pays 23.9× across 2199 companies we can price. Its own industry sits at 33.2×, across 5 companies. It is against its own five-year median of 69.7×, the 45th percentile of its own range.

Whether growth justifies the valuation

Its earnings are falling, so growth cannot justify the price.

	Profit growth	Price per ₹1 profit	Per 1% growth
Arvee Laboratories (India) Limited — this one	-17%/yr	57.7×	—
Aether Industries Limited	20%/yr	96.7×	₹4.8
Deepak Nitrite Limited	-13%/yr	27.0×	—
Atul Limited	9%/yr	21.6×	₹2.4
Aarti Industries Limited	-9%/yr	33.2×	—
Fine Organic Industries Limited	-13%/yr	36.9×	—

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Specialty Chemicals), it ranks 48 of 73 on returns, 71 of 72 on growth, 45 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 7.5% on capital, ahead of 34% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

No — Over the last five years it made ₹7 crore of cash from the business but spent ₹11 crore on plant and equipment, ₹4 crore more than it made, paid from its own cash and investments. And the profit is real: of every 100 rupees it reported over 10 years, about 173 arrived as cash — well above the profit; depreciation and interest are the reason, not a windfall. Its cash comes back more slowly than it used to: it went from being waiting 50.0 days for its cash to waiting 168.4 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

8 of 9 checks clear · 89%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 7 Aug 2026 · Standalone · Unaudited

Revenue

₹17 Cr

Net profit

₹2 Cr

EPS

₹1.54

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap: ₹234 Cr
Prev close: ₹212.08
52w High: ₹291
52w Low: ₹129
Enterprise value: ₹234 Cr
Beta: 0.6
Price CAGR 1y: 27.0%
Price CAGR 3y: 23.0%
Price CAGR 5y: 19.0%
Price CAGR 10y: —

Ratios

Return on assets: 5.9%
PEG ratio: -3.4
P/E ratio: 57.7
P/B ratio: 6.9
EV / EBITDA: 73.6
Industry P/E: 32.7
ROCE: 7.5%
ROCE 5y average: 12.0%
ROE: 7.8%
Debt / Equity: 0.0
Interest coverage: 11.6
Dividend yield: 0.0%
ROE 3y average: 6.0%
ROE last year: 7.0%

Annual P&L

Annual revenue: ₹32 Cr
Annual profit: ₹3 Cr
Operating margin: 10.1%
Net profit margin: 8.0%
EBITDA margin: 10.1%
Sales growth 3y: -19.9%
Sales growth 5y: -7.8%
Profit growth 3y: -17.0%
Profit growth 5y: -1.0%
EPS: ₹2.3
Sales growth TTM: 17.0%
Profit growth TTM: 196.0%
Dividend payout: 0.0%

Quarter P&L

Sales latest quarter: ₹17 Cr
Profit latest quarter: ₹2 Cr
YoY quarterly sales growth: 130.3%
YoY quarterly profit growth: 894.1%
OPM latest quarter: 14.4%

Balance Sheet

Book Value: ₹30.7
Face Value: ₹10.0
Total debt: ₹1 Cr
Total cash: ₹3 Cr
Borrowings: ₹1 Cr
Reserves / Equity: 2.1

Cash Flow

Operating cash flow: -₹0 Cr
Free cash flow: -₹3 Cr
FCF yield: -1.4%
Net cash flow: ₹0 Cr

Shareholding

Promoter holding: 73.5%
FII holding: —
DII holding: —
Public holding: 26.5%

Peer comparison

Company	Price ₹	P/E	Mkt cap ₹ Cr	Div yield %	Profit qtr ₹ Cr	Profit var %	Sales qtr ₹ Cr	Sales var %	ROCE %
Pidilite Inds.	1,488.50	57.3	1,51,685	0.77	883.5	28.2	4,551.6	21.3	31.0
Gujarat Fluoroch	4,555.90	80.8	49,893	0.07	219.0	21.4	1,588.0	24.0	9.6
Navin Fluo.Intl.	8,490.00	54.8	43,545	0.18	243.3	107.7	1,045.1	44.1	21.0
Aether Industri.	1,787.60	98.9	23,724	0.00	62.8	28.0	326.6	27.3	11.9
Deepak Nitrite	1,553.90	26.8	21,198	0.48	345.0	207.5	2,577.6	36.4	11.4
Aarti Industries	491.25	34.2	17,842	0.20	155.0	256.5	2,387.0	42.5	6.9
Atul	5,999.50	22.2	17,660	0.50	253.9	92.0	1,848.0	25.0	14.9
Arvee Laborat.	211.79	57.6	233	0.00	1.7	894.1	17.2	130.3	7.5
Median	367.30	29.7	1,098	0.24	13.5	52.2	175.3	26.4	13.8

Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Standalone · to 30 Jun 2026

Line item	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	7.60	8.91	7.70	6.14	11	13	8.91	6.45	7.48	3.45	9.78	11	17
Expenses	6.62	8.22	7.17	5.35	9.06	11	8.57	6.23	7.14	3.33	8.15	9.70	15
Material Cost								2.55	5.48	3.96	3.83	4.92	9.17
Change in Inventories								-0.24	-2.06	-3.84	0.98	1.40	2.08
Purchases of Stock-in-Trade								0	0	0	0	0	0
Employee Cost								1.15	1.68	0.66	1.12	1.02	1.55
Other Expenses								2.77	2.04	2.54	2.23	2.36	1.93
Operating Profit	0.98	0.69	0.53	0.79	1.54	1.50	0.34	0.22	0.34	0.12	1.63	1.10	2.49
OPM %	13	7.74	6.88	13	15	12	3.82	3.41	4.55	3.48	17	10	14
Other Income	0.09	0.09	0.19	0.21	0.11	0.16	0.19	0.21	0.17	0.23	0.14	0.15	0.18
Exceptional items (within Other Income)								0	0	0	0	0	0
Interest	0.07	0.08	0.05	0.05	0.08	0.05	0.05	0.07	0.04	0.04	0.07	0.08	0.06
Depreciation	0.35	0.42	0.35	0.37	0.31	0.30	0.28	0.27	0.29	0.30	0.30	0.31	0.32
Profit before tax	0.65	0.28	0.32	0.58	1.26	1.31	0.20	0.09	0.18	0.01	1.40	0.86	2.29
Tax %	25	25	25	81	25	25	25	22	5.56	0	-31	38	26
Net Profit	0.49	0.21	0.24	0.12	0.94	0.98	0.15	0.07	0.17	0.01	1.83	0.52	1.69
EPS in Rs	0.44	0.19	0.22	0.11	0.85	0.89	0.14	0.06	0.15	0.01	1.66	0.47	1.53
Diluted EPS in Rs								0.06	0.15	0.01	1.66	0.47	1.54

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Standalone · to 31 Mar 2026

Line item	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	27	34	48	55	45	47	40	61	30	38	32	41
Expenses	22	29	41	49	39	41	35	54	27	35	28	36
Material Cost										19	18
Change in Inventories										1.81	-3.53
Purchases of Stock-in-Trade										0	0
Employee Cost										4.49	4.47
Other Expenses										9.70	9.18
Operating Profit	4.99	5.90	7.17	6.17	6.02	6.07	5.68	7.29	2.94	3.61	3.18	5.34
OPM %	19	17	15	11	13	13	14	12	9.69	9.38	10	13
Other Income	0.10	0.51	0.23	0.35	0.35	0.56	0.46	1.35	0.64	0.66	0.69	0.70
Exceptional items (within Other Income)										0	0
Interest	3.07	3.48	3.33	1.63	0.99	0.58	0.37	0.39	0.25	0.25	0.23	0.25
Depreciation	1.49	2.07	2.15	2.35	2.29	2.41	2.32	2.08	1.50	1.15	1.21	1.23
Profit before tax	0.53	0.86	1.92	2.54	3.09	3.64	3.45	6.17	1.83	2.87	2.43	4.56
Tax %	66	-81	43	11	26	26	26	33	43	25	-3.70
Net Profit	0.19	1.55	1.09	2.26	2.30	2.68	2.57	4.12	1.05	2.15	2.53	4.05
EPS in Rs	0.23	1.91	0.99	2.05	2.09	2.43	2.33	3.74	0.95	1.95	2.30	3.67
Diluted EPS in Rs										1.95	2.29
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years: 2%
5 years: -8%
3 years: -20%
TTM: 17%

Compounded profit growth

10 years: 29%
5 years: -1%
3 years: -17%
TTM: 196%

Stock price CAGR

10 years: —
5 years: 19%
3 years: 23%
1 year: 27%

Return on equity

10 years: 10%
5 years: 9%
3 years: 6%
Last year: 7%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Standalone

Line item	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.05	4.05	5.51	5.51	5.51	11	11	11	11	11	11
Reserves	-1.41	0.15	8.69	11	13	10	13	17	18	20	23
Borrowings	25	25	16	13	3.87	8.88	3.13	1	1	1.03	1.11
Other Liabilities	7.25	6.49	14	7.81	11	11	12	9.63	8.45	5.29	7.99
Total Liabilities	35	36	44	37	34	41	39	39	39	38	43
Fixed Assets	13	17	15	13	13	14	14	13	13	15	17
CWIP	4.30	0	1.18	2.32	1.78	0.97	0.98	1.53	2.62	0.73	0.90
Investments	0	0	0	1.95	3.09	2.03	0	0	0	0	1.70
Other Assets	18	19	28	20	16	24	24	24	23	22	24
Total Assets	35	36	44	37	34	41	39	39	39	38	43

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Standalone

Line item	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	4.03	6.02	9.46	10	1.71	0.68	2.93	3.66	-0.21	-0.12
Cash from Investing Activity	-1.40	-1.23	-2.85	-3.08	-0.60	0.06	-1.26	-2.16	-1.32	0.50
Cash from Financing Activity	-2.92	-3.78	-4.92	-9.90	4.52	-6.06	-2.42	-0.19	-0.12	-0.16
Net Cash Flow	-0.29	1	1.68	-2.67	5.63	-5.32	-0.75	1.31	-1.64	0.23
Free Cash Flow	2.54	4.68	7.96	8.02	-0.53	-1.68	1.47	1.07	-2.06	-2.95

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Standalone

Line item	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	83	87	118	53	52	61	110	73	73	80	121
Inventory Days	155	105	100	43	81	92	93	42	159	80	229
Days Payable	131	98	150	56	126	118	160	73	164	58	159
Cash Conversion Cycle	107	94	68	40	7.72	35	43	42	68	102	191
Working Capital Days	30	31	31	-6.52	10	-11	50	70	96	104	168
ROCE %		15	18	14	15	15	13	23	6.83	9.58	7.53

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Standalone · to 30 Jun 2026

Line item	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	74	74	74	74	74	74	74	74	74	74	74	74
Public	27	27	27	27	27	27	27	27	27	27	27	27
No. of Shareholders	905	1,372	1,298	1,480	1,416	1,623	1,576	1,505	1,505	1,861	1,638	1,596

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +31.3% (₹161.47 → ₹212.08)Brick size ₹17.14 (fixed)Bricks 20

Price moved up one brickPrice moved down one brickLast close ₹212.08 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

News

News and filings about Arvee Laboratories (India) Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

raw materials for contrast media intermediates, polymer modifiers and drug intermediates

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector: Chemicals
Industry: Specialty Chemicals
Classification: Chemicals › Specialty Chemicals
ISIN: INE006Z01016

Business segments

Non-Textile Segment · 86%
Textile Segment · 14%

Plants

Arvee Laboratories Vartej speciality chemicals plant

News impact

Big market events that reach Arvee Laboratories (India) Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Splits, bonuses & buybacks

daily-prices repair: 10 rows from NSE's archive (replace 5, delete 0, insert 5), 2018-03-05..2026-02-01 (docs/flat_day_repair.md)1× · 5 Mar 2018

Insider trades

Disclosed	Who	Type	Shares	Value ₹ Cr
28 Sep 2026	Saurin Ajitbhai Gandhi · KMP	SELL	3,010	0.07
28 Sep 2026	Saurin Ajitbhai Gandhi · KMP	SELL	990	0.02

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Annual report · 2025-263 Sep 2026
Annual report · 2024-2530 Aug 2025

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.